Investment Bank Updates Estimates for Waters, Bruker

genomeweb
360dx

Investment Bank Updates Estimates for Waters, Bruker

Jun 24, 2009

NEW YORK (GenomeWeb News) – Investment bank Leerink Swann today updated its revenue estimates for Waters and Bruker, raising its expectations for both firms for the second half of the year.

Isaac Ro, an analyst for the bank, issued research notes on both firms, reiterating his rating of "market perform" for their stocks.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

In Brief This Week: Novogene, Hologic, Agilent, Diagenode
Spontaneous Preterm Birth Clues Identified in Cervicovaginal Microbiome
Germany Plans Limited Coverage of NIPT for High-Risk Pregnancies
Bruker TB Test, PCR Platform Receives CE-IVD Mark
Single-Cell Sperm Sequencing Reveals New Details About Recombination
New Products Posted to GenomeWeb: Roche Diagnostics, Asuragen, Mission Bio

The Scan

Concerns About Bias in Policies

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Reprogrammable DNA

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Lack of Diversity

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

This Week in Science

In Science this week: whole-genome sequencing of single sperm cells, and more.

Menu